Inmolecule Nanotech, S.A. Logo

Inmolecule Nanotech, S.A.

Develops nanoparticles from plant compounds for biomedical and personal care products.

MLINA | Euronext Growth

Overview

Corporate Details

ISIN(s):
ES0105908000
LEI:
959800F0D3TQYVTXW034
Country:
Spain
Address:
N/A

Description

Inmolecule Nanotech, S.A. is a research and development company specializing in nanotechnology. The company operates a proprietary Nano-Phyto-Chemistry platform that utilizes plant-derived compounds and extracts at a nanometric scale. This technology manipulates chemical components such as flavonoids and terpenes to create active ingredient nanoparticles. The stated benefits of this process include enhanced bioavailability, reduced toxicity, and fewer inflammatory side effects. The company's developments are applied in the biomedical, home, and personal care sectors. Products derived from its platform include surface sanitizers, disinfectants, and dietary supplements.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Inmolecule Nanotech, S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Inmolecule Nanotech, S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Inmolecule Nanotech, S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.